Wells Fargo Maintains Equal-Weight on Edwards Lifesciences, Lowers Price Target to $75
Portfolio Pulse from Benzinga Newsdesk
Wells Fargo analyst Larry Biegelsen has maintained an Equal-Weight rating on Edwards Lifesciences (NYSE:EW) and lowered the price target from $88 to $75.
October 26, 2023 | 12:55 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Wells Fargo has maintained an Equal-Weight rating on Edwards Lifesciences and lowered the price target from $88 to $75.
The lowering of the price target by Wells Fargo indicates a potential decrease in the stock's value. This could lead to a negative short-term impact on Edwards Lifesciences' stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100